Abstract

Ten obsessive-compulsive patients received single-blind treatment with fluvoxamine, a selective serotonin reuptake inhibitor, for several weeks following at least 2 weeks of placebo. The group showed significant improvement, as measured by several clinical scales and self-ratings; six patients were judged responders. Fluvoxamine appears effective in treating severe obsessive-compulsive disorder.

Keywords

FluvoxamineLoginObsessive compulsivePsychiatrySerotonin Uptake InhibitorsMedicinePsychologyFluoxetineComputer scienceSerotoninInternal medicine

Related Publications

Publication Info

Year
1987
Type
article
Volume
144
Issue
8
Pages
1059-1061
Citations
118
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

118
OpenAlex

Cite This

L H Price, W K Goodman, D S Charney et al. (1987). Treatment of severe obsessive-compulsive disorder with fluvoxamine. American Journal of Psychiatry , 144 (8) , 1059-1061. https://doi.org/10.1176/ajp.144.8.1059

Identifiers

DOI
10.1176/ajp.144.8.1059